A delegation of the Russian Ministry of Industry and Trade lead by the Head of the Department of Pharmaceutical and Medical Industry Development – arrived in Italy with a mission to support cooperation between the countries.
Takeda, a pharmaceutical company, has developed an innovative sugar-lowering drug that is a combination of alogliptin and metformin. The representatives of the company announced that the drug was launched in the Russian market.
Janssen Pharmaceutica N.V., a part of Janssen Pharmaceutical Companies of Johnson & Johnson, signed a memorandum of intent with Pharmstandard JSC to manufacture and supply Sirturo®, a medicinal product.
In the near future, the company will localize the manufacturing of several innovative products in Russia. The transfer of manufacturing to Russia will increase the availability of the drug and contribute to reducing its price.
During the meeting of the Governor of Tver region Igor Rudenya with Mikhail Petukhov, General Director of B. Brown Medical LLC, and Maxim Zakharchenko, General Director of Gematek LLC, there was a discussion